Editorial pubs.acs.org/jmc
Cite This: J. Med. Chem. XXXX, XXX, XXX−XXX
Allosteric Modulators of Drug Targets Special Issue online landing page dedicated to “Allosteric Modulators of Drug Targets.” We invite you to be part of ACS history and contribute to the field’s knowledge of “Allosteric Modulators of Drug Targets”.
C
all for papers! The Journal of Medicinal Chemistry is sending out a call for manuscripts for a special issue entitled “Allosteric Modulators of Drug Targets”. This special issue is a cross-thematic issue with ACS Medicinal Chemistry Letters and ACS Chemical Neuroscience. The Journal of Medicinal Chemistry special issue is scheduled for publication in January 2019. Allosteric modulators of drug targets are an emerging area within the past 2 decades. The advancement of technologies including bioassays, computational models of mechanism of action, and ligand design platforms has led to the discovery and characterization of allosteric modulators for G-protein-coupled receptors (GPCRs) and several other drug targets. For this cross-thematic issue, the Journal of Medicinal Chemistry will publish Perspectives, Articles, Brief Articles, and Drug Annotations that highlight the discovery and development of allosteric modulators for GPCRs and any other molecular drug target and involve structure−activity relationship (SAR) studies using state-of-the-art medicinal chemistry and bioassay technologies. Traditional medicinal chemistry approaches are also welcome if they identify a new molecular mechanism or drug target that can be modulated by allosteric modulators. Manuscripts on the discovery and characterization of endogenous allosteric modulators are highly encouraged. ACS Medicinal Chemistry Letters and ACS Chemical Neuroscience welcome contributions within the scope of their journals and call for papers for this cross-thematic special issue. The simultaneous publication of a series of communications, articles, and reviews in the three journals should provide an excellent forum for researchers to share their most important recent findings and offer exceptional exposure of the published articles to the scientific community. We hope that the special issues will advance knowledge and stimulate new collaborations and new research directions. The Guest Editors, Carrie Haskell-Luevano (University of Minnesota) for the Journal of Medicinal Chemistry, Craig Lindsley (Vanderbilt University) for ACS Chemical Neuroscience, and Nicholas Carruthers (Johnson & Johnson), Tim Lovenberg (Johnson & Johnson), and Stephen Traynelis (Emory University) for ACS Medicinal Chemistry Letters will be working together to publish these thematic issues in January of 2019. We encourage you to submit your manuscripts at https:// acsparagonplus.acs.org by the end of June 2018 for Articles, Brief Articles, and Drug Annotations. Please select “Allosteric Modulators” from the special issue dropdown box in our submission system. If you are interested in submitting a Perspectives manuscript for the Journal of Medicinal Chemistry, please contact Nicholas Meanwell at
[email protected]. org. Perspectives would need to be submitted by May 2018. Accepted papers for the thematic issues can appear online as Just Accepted Manuscripts (JAMS) and As Soon As Publishable (ASAP) manuscripts. They can then be cited at any time thereafter but are scheduled to appear together in a January 2019 special issue. In addition, articles will appear on a special © XXXX American Chemical Society
Carrie Haskell-Luevano, Associate Editor and Guest Editor Gunda I. Georg, Editor-in-Chief Shaomeng Wang, Editor-in-Chief Nicholas Meanwell, Perspectives Editor
■
AUTHOR INFORMATION
ORCID
Carrie Haskell-Luevano: 0000-0002-6783-5972 Gunda I. Georg: 0000-0002-8900-9460 Nicholas Meanwell: 0000-0002-8857-1515 Notes
Views expressed in this editorial are those of the authors and not necessarily the views of the ACS.
A
DOI: 10.1021/acs.jmedchem.8b00171 J. Med. Chem. XXXX, XXX, XXX−XXX
